We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

110 hedge funds and large institutions have $490M invested in Editas Medicine in 2017 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 15

61% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 18

58% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $6.88M

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

11% more funds holding

Funds holding: 99 → 110 (+11)

3.02% more ownership

Funds ownership: 67.63% → 70.65% (+3%)

20% less capital invested

Capital invested by funds: $614M → $490M (-$124M)

Holders
110
Holders Change
+11
Holders Change %
+11.11%
% of All Funds
2.74%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
29
Increased
42
Reduced
15
Closed
18
Calls
$10.8M
Puts
$6.88M
Net Calls
+$3.96M
Net Calls Change
+$6.32M

Top Buyers

1
BlackRock
BlackRock
New York
+$25.5M
2
EC
EcoR1 Capital
California
+$12.9M
3
State Street
State Street
Massachusetts
+$7.3M
4
AIM
ARK Investment Management
Florida
+$5.05M
5
Northern Trust
Northern Trust
Illinois
+$4.78M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.5M
2
PVMCV
Polaris Venture Management Co VI
Massachusetts
-$18M
3
CCP
Clough Capital Partners
Massachusetts
-$8.75M
4
Millennium Management
Millennium Management
New York
-$7.21M
5
HCMT
Highland Capital Management (Texas)
Texas
-$4.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$80M -$20.5M -1,135,848 -19%
FP
2
Flagship Pioneering
Massachusetts
$56.7M – – –
PVMCV
3
Polaris Venture Management Co VI
Massachusetts
$46.9M -$18M -1,000,000 -26%
BlackRock
4
BlackRock
New York
$42.5M +$25.5M +1,413,510 +126%
Vanguard Group
5
Vanguard Group
Pennsylvania
$36.5M +$4.36M +241,973 +13%
Capital World Investors
6
Capital World Investors
California
$29.7M – – –
DM
7
Deerfield Management
New York
$28.7M – – –
Viking Global Investors
8
Viking Global Investors
Connecticut
$28.7M – – –
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$24.5M +$1.06M +59,034 +4%
EC
10
EcoR1 Capital
California
$12M +$12.9M +717,107 New
State Street
11
State Street
Massachusetts
$9.02M +$7.3M +405,022 +305%
AIM
12
ARK Investment Management
Florida
$8.56M +$5.05M +280,265 +122%
Morgan Stanley
13
Morgan Stanley
New York
$7.75M +$2.75M +152,791 +49%
Northern Trust
14
Northern Trust
Illinois
$6.26M +$4.78M +265,273 +246%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.78M +$2.99M +165,703 +139%
Goldman Sachs
16
Goldman Sachs
New York
$4.58M +$4.3M +238,707 +691%
GIM
17
Granahan Investment Management
Massachusetts
$3.79M +$4.07M +225,720 New
CS
18
Credit Suisse
Switzerland
$3.15M +$605K +33,570 +22%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$2.88M -$1.32M -73,503 -30%
Millennium Management
20
Millennium Management
New York
$2.76M -$7.21M -400,051 -71%
YCMGA
21
York Capital Management Global Advisors
New York
$2.59M +$79.4K +4,407 +3%
TCIM
22
TIAA CREF Investment Management
New York
$2.51M +$2.37M +131,389 +716%
CAG
23
Crestwood Advisors Group
Massachusetts
$2.39M +$422K +23,411 +20%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$2.38M +$1.42M +78,632 +124%
CC
25
Casdin Capital
New York
$2.24M – – –
1
2 3 4 5

EDIT Hedge Fund Activity: Q2 2017 in Review

110 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2017, worth a combined $490M — down 20% from $614M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new EDIT positions and 18 closed out — a net gain of 11 holders — while 42 added to existing stakes and 15 trimmed.

The largest buyer was BlackRock, adding an estimated $25.5M. The largest seller was Fidelity Investments, cutting an estimated $20.5M.

  • 110 institutional investors held Editas Medicine (EDIT) as of Q2 2017, up from 99 in Q1 2017.
  • Funds reported $490M of Editas Medicine stock for Q2 2017, down 20% quarter-over-quarter.
  • 29 funds opened new Editas Medicine positions in Q2 2017 and 18 closed out, a net change of +11 holders.
  • The largest Editas Medicine buyer in Q2 2017 was BlackRock, an estimated $25.5M added.
  • The largest Editas Medicine seller in Q2 2017 was Fidelity Investments, an estimated $20.5M sold.

Based on aggregated 13F filings for Q2 2017.